BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Doxycycline, rs2230926, LEP, cell-cell adhesion, Arthritis, Liver, Anticancer prodrugs)
Bookmark Forward

QuickView for GR 38032F (compound)


Genetic Markers

Most Correlated Genes

  1. HTR3A
  2. CGGBP1
  3. ABCA1
  4. JAG2
  5. CYP1B1
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. response to organic substance
  2. regulation of nitrogen compound metabolic process
  3. cell differentiation
  4. positive regulation of protein metabolic process
  5. cytoplasmic vesicle
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Drug Matrix In Vivo Toxicogenomic Study - Rat Intestine [Codelink]
  2. Drug target sets for approved compounds
  3. Broad Connectivity Map (CMAP 2.0) compound database
  4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
  5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. The Effect of Granisetron, Ondansetron, and Meperidine in Preventing Postoperative Shivering: Contro…
  2. Diagnosis of Serious Conditions Delayed in Association with Ondansetron Treatment for Vomiting in th…
  3. Central Composite Designed Fast Dissolving Tablets for Improved Solubility of the Loaded Drug Ondans…
  4. Embryo-fetal safety evaluation of ondansetron in rats.
  5. Ondansetron Safety Regarding Prolong QTc for Children with Head Trauma.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant
  2. Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and V…
  3. Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC)
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.